$NAVB Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in NAVIDEA BIOPHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in NAVIDEA BIOPHARMACEUTICALS, INC.. Get notifications about new insider transactions in NAVIDEA BIOPHARMACEUTICALS, INC. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 31 2011 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | Director | Buy | X | 0.00 | 20,000 | 0 | 213,746 | 193.7 K to 213.7 K (+10.32 %) |
May 31 2011 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | Director | Buy | X | 0.31 | 320,000 | 99,200 | 3,013,328 | 2.7 M to 3 M (+11.88 %) |
May 31 2011 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | Director | Buy | X | 0.32 | 450,000 | 144,000 | 2,693,328 | 2.2 M to 2.7 M (+20.06 %) |
May 31 2011 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | Director | Grant | A | 0.00 | 400,000 | 0 | 2,243,328 | 1.8 M to 2.2 M (+21.70 %) |
May 31 2011 | NAVB | NAVIDEA BIOPHARMAC ... | Aschinger Carl J Jr | Director | Sell | S | 5.03 | 80,000 | 402,400 | 158,300 | 238.3 K to 158.3 K (-33.57 %) |
Apr 15 2011 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Option Exercise | M | 0.26 | 200,000 | 52,000 | 0 | |
Apr 15 2011 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Option Exercise | M | 0.27 | 300,000 | 81,000 | 0 | |
Apr 15 2011 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Option Exercise | M | 0.39 | 200,000 | 78,000 | 0 | |
Apr 15 2011 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Option Exercise | M | 0.49 | 150,000 | 73,500 | 0 | |
Apr 15 2011 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Option Exercise | M | 0.13 | 70,000 | 9,100 | 0 | |
Apr 15 2011 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Option Exercise | M | 0.14 | 100,000 | 14,000 | 0 | |
Apr 15 2011 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Option Exercise | M | 0.30 | 125,000 | 37,500 | 0 | |
Apr 15 2011 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Option Exercise | M | 0.42 | 180,000 | 75,600 | 0 | |
Apr 15 2011 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Option Exercise | M | 0.36 | 200,000 | 72,000 | 0 | |
Apr 15 2011 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Option Exercise | C | 0.31 | 1,613,000 | 500,030 | 1,613,000 | |
Apr 15 2011 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Option Exercise | C | 0.31 | 3,225,806 | 1,000,000 | 0 | |
Apr 15 2011 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Payment of Exercise | F | 0.32 | 637,321 | 203,943 | 1,843,328 | 2.5 M to 1.8 M (-25.69 %) |
Apr 15 2011 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Buy | M | 0.13 | 70,000 | 9,100 | 2,480,649 | 2.4 M to 2.5 M (+2.90 %) |
Apr 15 2011 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Buy | M | 0.14 | 100,000 | 14,000 | 2,410,649 | 2.3 M to 2.4 M (+4.33 %) |
Apr 15 2011 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Buy | M | 0.30 | 125,000 | 37,500 | 2,310,649 | 2.2 M to 2.3 M (+5.72 %) |
Apr 15 2011 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Buy | M | 0.49 | 150,000 | 73,500 | 2,185,649 | 2 M to 2.2 M (+7.37 %) |
Apr 15 2011 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Buy | M | 0.42 | 180,000 | 75,600 | 2,035,649 | 1.9 M to 2 M (+9.70 %) |
Apr 15 2011 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Buy | M | 0.26 | 200,000 | 52,000 | 1,855,649 | 1.7 M to 1.9 M (+12.08 %) |
Apr 15 2011 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Buy | M | 0.36 | 200,000 | 72,000 | 1,655,649 | 1.5 M to 1.7 M (+13.74 %) |
Apr 15 2011 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Buy | M | 0.39 | 200,000 | 78,000 | 1,455,649 | 1.3 M to 1.5 M (+15.93 %) |
Apr 15 2011 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Buy | M | 0.27 | 300,000 | 81,000 | 1,255,649 | 955.6 K to 1.3 M (+31.39 %) |
Apr 15 2011 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Sell | W | 0.00 | 40,000 | 0 | 940,649 | 980.6 K to 940.6 K (-4.08 %) |
Dec 27 2010 | NAVB | NAVIDEA BIOPHARMAC ... | Aschinger Carl J Jr | Director | Buy | P | 1.95 | 110 | 215 | 320 | 210 to 320 (+52.38 %) |
Dec 27 2010 | NAVB | NAVIDEA BIOPHARMAC ... | Aschinger Carl J Jr | Director | Buy | P | 1.92 | 100 | 192 | 210 | 110 to 210 (+90.91 %) |
Dec 22 2010 | NAVB | NAVIDEA BIOPHARMAC ... | BROWN RODGER A | Vice President | Option Exercise | A | 1.90 | 60,000 | 114,000 | 60,000 | |
Dec 22 2010 | NAVB | NAVIDEA BIOPHARMAC ... | Rash Douglas L | Vice President, Mar ... | Option Exercise | A | 1.90 | 60,000 | 114,000 | 60,000 | |
Dec 22 2010 | NAVB | NAVIDEA BIOPHARMAC ... | LARSON BRENT L | VP Finance and CFO | Option Exercise | A | 1.90 | 95,000 | 180,500 | 95,000 | |
Dec 22 2010 | NAVB | NAVIDEA BIOPHARMAC ... | Cope Frederick O | Vice President | Option Exercise | A | 1.90 | 120,000 | 228,000 | 120,000 | |
Dec 22 2010 | NAVB | NAVIDEA BIOPHARMAC ... | Blair Anthony K | VP-Manufacturing & ... | Option Exercise | A | 1.90 | 60,000 | 114,000 | 60,000 | |
Dec 21 2010 | NAVB | NAVIDEA BIOPHARMAC ... | Aschinger Carl J Jr | Director | Buy | P | 1.95 | 110 | 215 | 110 | 0 to 110 |
Dec 16 2010 | NAVB | NAVIDEA BIOPHARMAC ... | LARSON BRENT L | VP Finance and CFO | Option Exercise | M | 0.41 | 60,000 | 24,600 | 0 | |
Dec 16 2010 | NAVB | NAVIDEA BIOPHARMAC ... | LARSON BRENT L | VP Finance and CFO | Payment of Exercise | F | 1.97 | 28,380 | 55,909 | 154,912 | 183.3 K to 154.9 K (-15.48 %) |
Dec 16 2010 | NAVB | NAVIDEA BIOPHARMAC ... | LARSON BRENT L | VP Finance and CFO | Buy | M | 0.41 | 60,000 | 24,600 | 183,292 | 123.3 K to 183.3 K (+48.66 %) |
Dec 16 2010 | NAVB | NAVIDEA BIOPHARMAC ... | BROWN RODGER A | Vice President | Option Exercise | M | 0.41 | 45,000 | 18,450 | 0 | |
Dec 16 2010 | NAVB | NAVIDEA BIOPHARMAC ... | BROWN RODGER A | Vice President | Payment of Exercise | F | 1.97 | 21,285 | 41,931 | 28,715 | 50 K to 28.7 K (-42.57 %) |
Dec 16 2010 | NAVB | NAVIDEA BIOPHARMAC ... | BROWN RODGER A | Vice President | Buy | M | 0.41 | 45,000 | 18,450 | 50,000 | 5 K to 50 K (+900.00 %) |
Dec 10 2010 | NAVB | NAVIDEA BIOPHARMAC ... | Johnson Owen E | Director | Buy | P | 2.05 | 25,000 | 51,230 | 70,000 | 45 K to 70 K (+55.56 %) |
Nov 18 2010 | NAVB | NAVIDEA BIOPHARMAC ... | Cope Frederick O | Vice President | Buy | P | 1.76 | 5,000 | 8,800 | 5,000 | 0 to 5 K |
Nov 17 2010 | NAVB | NAVIDEA BIOPHARMAC ... | Troup Gordon A | Director | Buy | P | 1.75 | 10,000 | 17,450 | 40,000 | 30 K to 40 K (+33.33 %) |
Nov 16 2010 | NAVB | NAVIDEA BIOPHARMAC ... | PYKETT MARK JEROME | EVP | Option Exercise | A | 1.70 | 200,000 | 340,000 | 200,000 | |
Nov 16 2010 | NAVB | NAVIDEA BIOPHARMAC ... | FORD BRENDAN A | Director | Buy | P | 1.75 | 5,000 | 8,725 | 30,000 | 25 K to 30 K (+20.00 %) |
Nov 16 2010 | NAVB | NAVIDEA BIOPHARMAC ... | FORD BRENDAN A | Director | Buy | P | 1.75 | 5,000 | 8,750 | 25,000 | 20 K to 25 K (+25.00 %) |
Nov 16 2010 | NAVB | NAVIDEA BIOPHARMAC ... | FORD BRENDAN A | Director | Buy | P | 1.73 | 7,500 | 12,975 | 20,000 | 12.5 K to 20 K (+60.00 %) |
Nov 16 2010 | NAVB | NAVIDEA BIOPHARMAC ... | FORD BRENDAN A | Director | Buy | P | 1.77 | 12,500 | 22,125 | 12,500 | 0 to 12.5 K |
Nov 16 2010 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Buy | P | 1.77 | 5,000 | 8,850 | 995,649 | 990.6 K to 995.6 K (+0.50 %) |
Nov 16 2010 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Buy | P | 1.76 | 10,000 | 17,600 | 990,649 | 980.6 K to 990.6 K (+1.02 %) |
Nov 16 2010 | NAVB | NAVIDEA BIOPHARMAC ... | Aschinger Carl J Jr | Director | Buy | P | 1.73 | 2,000 | 3,460 | 238,300 | 236.3 K to 238.3 K (+0.85 %) |
Nov 16 2010 | NAVB | NAVIDEA BIOPHARMAC ... | Aschinger Carl J Jr | Director | Buy | P | 1.74 | 13,000 | 22,620 | 236,300 | 223.3 K to 236.3 K (+5.82 %) |
Jun 21 2010 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Option Exercise | M | 0.41 | 90,000 | 36,900 | 0 | |
Jun 21 2010 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Gift | G | 0.00 | 30,000 | 0 | 980,649 | 1 M to 980.6 K (-2.97 %) |
Jun 21 2010 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Buy | M | 0.41 | 90,000 | 36,900 | 1,010,649 | 920.6 K to 1 M (+9.78 %) |
Jun 17 2010 | NAVB | NAVIDEA BIOPHARMAC ... | MILLER FRED B | Director | Buy | P | 1.56 | 10,000 | 15,600 | 91,000 | 81 K to 91 K (+12.35 %) |
May 12 2010 | NAVB | NAVIDEA BIOPHARMAC ... | Aschinger Carl J Jr | Director | Buy | P | 1.80 | 1,200 | 2,160 | 223,300 | 222.1 K to 223.3 K (+0.54 %) |
May 04 2010 | NAVB | NAVIDEA BIOPHARMAC ... | Aschinger Carl J Jr | Director | Buy | P | 1.81 | 5,000 | 9,050 | 222,100 | 217.1 K to 222.1 K (+2.30 %) |
May 04 2010 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Buy | P | 1.82 | 6,080 | 11,066 | 920,649 | 914.6 K to 920.6 K (+0.66 %) |
May 04 2010 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Buy | P | 1.81 | 7,400 | 13,394 | 914,569 | 907.2 K to 914.6 K (+0.82 %) |
May 04 2010 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Buy | P | 1.80 | 16,520 | 29,736 | 907,169 | 890.6 K to 907.2 K (+1.85 %) |
Mar 23 2010 | NAVB | NAVIDEA BIOPHARMAC ... | Johnson Owen E | Director | Buy | P | 1.90 | 10,000 | 19,000 | 45,000 | 35 K to 45 K (+28.57 %) |
Mar 18 2010 | NAVB | NAVIDEA BIOPHARMAC ... | AVITAL REUVEN | Director | Buy | P | 2.10 | 10,000 | 21,000 | 150,000 | 140 K to 150 K (+7.14 %) |
Dec 31 2009 | NAVB | NAVIDEA BIOPHARMAC ... | WHITLEY J FRANK | Director | Option Exercise | M | 0.50 | 30,000 | 15,000 | 0 | |
Dec 31 2009 | NAVB | NAVIDEA BIOPHARMAC ... | WHITLEY J FRANK | Director | Buy | M | 0.50 | 30,000 | 15,000 | 61,500 | 31.5 K to 61.5 K (+95.24 %) |
Dec 23 2009 | NAVB | NAVIDEA BIOPHARMAC ... | Aschinger Carl J Jr | Director | Buy | P | 1.07 | 200 | 214 | 200 | 0 to 200 |
Dec 18 2009 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Option Exercise | M | 0.50 | 45,000 | 22,500 | 0 | |
Dec 18 2009 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Payment of Exercise | F | 1.17 | 27,851 | 32,586 | 890,649 | 918.5 K to 890.6 K (-3.03 %) |
Dec 18 2009 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Buy | M | 0.50 | 45,000 | 22,500 | 918,500 | 873.5 K to 918.5 K (+5.15 %) |
Nov 25 2009 | NAVB | NAVIDEA BIOPHARMAC ... | Aschinger Carl J Jr | Director | Buy | P | 1.00 | 7,000 | 7,000 | 217,100 | 210.1 K to 217.1 K (+3.33 %) |
Nov 24 2009 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Buy | P | 1.04 | 10,000 | 10,400 | 873,500 | 863.5 K to 873.5 K (+1.16 %) |
Nov 24 2009 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Buy | P | 1.05 | 500 | 525 | 863,500 | 863 K to 863.5 K (+0.06 %) |
Nov 24 2009 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Buy | P | 1.07 | 4,000 | 4,280 | 863,000 | 859 K to 863 K (+0.47 %) |
Nov 24 2009 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Buy | P | 1.04 | 5,500 | 5,720 | 859,000 | 853.5 K to 859 K (+0.64 %) |
Nov 24 2009 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Buy | P | 1.06 | 10,000 | 10,600 | 853,500 | 843.5 K to 853.5 K (+1.19 %) |
Nov 10 2009 | NAVB | NAVIDEA BIOPHARMAC ... | Troup Gordon A | Director | Buy | P | 0.68 | 3,500 | 2,380 | 30,000 | 26.5 K to 30 K (+13.21 %) |
Nov 10 2009 | NAVB | NAVIDEA BIOPHARMAC ... | Troup Gordon A | Director | Buy | P | 0.70 | 11,500 | 8,050 | 26,500 | 15 K to 26.5 K (+76.67 %) |
Nov 03 2009 | NAVB | NAVIDEA BIOPHARMAC ... | Rash Douglas L | Vice President, Mar ... | Option Exercise | A | 1.10 | 35,000 | 38,500 | 35,000 | |
Nov 03 2009 | NAVB | NAVIDEA BIOPHARMAC ... | Cope Frederick O | Vice President | Option Exercise | A | 1.10 | 75,000 | 82,500 | 75,000 | |
Nov 03 2009 | NAVB | NAVIDEA BIOPHARMAC ... | LARSON BRENT L | VP Finance and CFO | Option Exercise | A | 1.10 | 75,000 | 82,500 | 75,000 | |
Nov 03 2009 | NAVB | NAVIDEA BIOPHARMAC ... | Blair Anthony K | VP-Manufacturing & ... | Option Exercise | A | 1.10 | 75,000 | 82,500 | 75,000 | |
Nov 03 2009 | NAVB | NAVIDEA BIOPHARMAC ... | BROWN RODGER A | Vice President | Option Exercise | A | 1.10 | 50,000 | 55,000 | 50,000 | |
Oct 23 2009 | NAVB | NAVIDEA BIOPHARMAC ... | LARSON BRENT L | VP Finance and CFO | Option Exercise | M | 0.50 | 60,000 | 30,000 | 0 | |
Oct 23 2009 | NAVB | NAVIDEA BIOPHARMAC ... | LARSON BRENT L | VP Finance and CFO | Payment of Exercise | F | 1.20 | 36,708 | 44,050 | 123,292 | 160 K to 123.3 K (-22.94 %) |
Oct 23 2009 | NAVB | NAVIDEA BIOPHARMAC ... | LARSON BRENT L | VP Finance and CFO | Buy | M | 0.50 | 60,000 | 30,000 | 160,000 | 100 K to 160 K (+60.00 %) |
Sep 17 2009 | NAVB | NAVIDEA BIOPHARMAC ... | BROWN RODGER A | Vice President | Option Exercise | M | 0.50 | 35,000 | 17,500 | 0 | |
Sep 17 2009 | NAVB | NAVIDEA BIOPHARMAC ... | BROWN RODGER A | Vice President | Sell | S | 1.20 | 30,000 | 36,000 | 5,000 | 35 K to 5 K (-85.71 %) |
Sep 17 2009 | NAVB | NAVIDEA BIOPHARMAC ... | BROWN RODGER A | Vice President | Buy | M | 0.50 | 35,000 | 17,500 | 35,000 | 0 to 35 K |
Aug 14 2009 | NAVB | NAVIDEA BIOPHARMAC ... | Johnson Owen E | Director | Buy | P | 1.31 | 500 | 655 | 35,000 | 34.5 K to 35 K (+1.45 %) |
Aug 14 2009 | NAVB | NAVIDEA BIOPHARMAC ... | Johnson Owen E | Director | Buy | P | 1.34 | 1,000 | 1,340 | 34,500 | 33.5 K to 34.5 K (+2.99 %) |
Aug 14 2009 | NAVB | NAVIDEA BIOPHARMAC ... | Johnson Owen E | Director | Buy | P | 1.35 | 13,500 | 18,225 | 33,500 | 20 K to 33.5 K (+67.50 %) |
Jun 15 2009 | NAVB | NAVIDEA BIOPHARMAC ... | AVITAL REUVEN | Director | Buy | P | 0.95 | 22,300 | 21,185 | 140,000 | 117.7 K to 140 K (+18.95 %) |
Jun 10 2009 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Option Exercise | M | 0.50 | 45,000 | 22,500 | 135,000 | |
Jun 10 2009 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Option Exercise | M | 0.30 | 25,000 | 7,500 | 125,000 | |
Jun 10 2009 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Gift | G | 0.00 | 10,000 | 0 | 193,746 | 183.7 K to 193.7 K (+5.44 %) |
Jun 10 2009 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Gift | G | 0.00 | 40,000 | 0 | 843,500 | 883.5 K to 843.5 K (-4.53 %) |
Jun 10 2009 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Gift | G | 0.00 | 10,000 | 0 | 883,500 | 893.5 K to 883.5 K (-1.12 %) |
Jun 10 2009 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Buy | M | 0.30 | 25,000 | 7,500 | 893,500 | 868.5 K to 893.5 K (+2.88 %) |
Jun 10 2009 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Buy | M | 0.50 | 45,000 | 22,500 | 868,500 | 823.5 K to 868.5 K (+5.46 %) |
Jun 09 2009 | NAVB | NAVIDEA BIOPHARMAC ... | Aschinger Carl J Jr | Director | Buy | P | 1.01 | 400 | 404 | 210,100 | 209.7 K to 210.1 K (+0.19 %) |
May 29 2009 | NAVB | NAVIDEA BIOPHARMAC ... | Aschinger Carl J Jr | Director | Buy | P | 0.83 | 5,835 | 4,843 | 209,700 | 203.9 K to 209.7 K (+2.86 %) |
May 29 2009 | NAVB | NAVIDEA BIOPHARMAC ... | Aschinger Carl J Jr | Director | Buy | P | 0.81 | 7,500 | 6,075 | 203,865 | 196.4 K to 203.9 K (+3.82 %) |
May 29 2009 | NAVB | NAVIDEA BIOPHARMAC ... | Aschinger Carl J Jr | Director | Buy | P | 0.75 | 12,500 | 9,375 | 196,365 | 183.9 K to 196.4 K (+6.80 %) |
May 29 2009 | NAVB | NAVIDEA BIOPHARMAC ... | Aschinger Carl J Jr | Director | Buy | P | 0.84 | 13,365 | 11,227 | 183,865 | 170.5 K to 183.9 K (+7.84 %) |
Jun 04 2009 | NAVB | NAVIDEA BIOPHARMAC ... | AVITAL REUVEN | Director | Buy | P | 1.00 | 19,000 | 19,000 | 117,700 | 98.7 K to 117.7 K (+19.25 %) |
May 27 2009 | NAVB | NAVIDEA BIOPHARMAC ... | Aschinger Carl J Jr | Director | Buy | P | 0.68 | 3,000 | 2,040 | 170,500 | 167.5 K to 170.5 K (+1.79 %) |
May 27 2009 | NAVB | NAVIDEA BIOPHARMAC ... | Aschinger Carl J Jr | Director | Buy | P | 0.69 | 16,500 | 11,385 | 167,500 | 151 K to 167.5 K (+10.93 %) |
May 13 2009 | NAVB | NAVIDEA BIOPHARMAC ... | AVITAL REUVEN | Director | Buy | P | 0.60 | 800 | 480 | 98,700 | 97.9 K to 98.7 K (+0.82 %) |
May 13 2009 | NAVB | NAVIDEA BIOPHARMAC ... | AVITAL REUVEN | Director | Buy | P | 0.60 | 17,900 | 10,740 | 97,900 | 80 K to 97.9 K (+22.38 %) |
Mar 30 2009 | NAVB | NAVIDEA BIOPHARMAC ... | WHITLEY J FRANK | Director | Buy | P | 0.53 | 10,000 | 5,300 | 31,500 | 21.5 K to 31.5 K (+46.51 %) |
Mar 10 2009 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Option Exercise | X | 0.50 | 50,000 | 25,000 | 0 | |
Mar 10 2009 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Buy | X | 0.50 | 50,000 | 25,000 | 823,500 | 773.5 K to 823.5 K (+6.46 %) |
Jan 07 2009 | NAVB | NAVIDEA BIOPHARMAC ... | WHITLEY J FRANK | Director | Option Exercise | A | 0.59 | 10,000 | 5,900 | 10,000 | |
Feb 18 2009 | NAVB | NAVIDEA BIOPHARMAC ... | Cope Frederick O | Vice President | Option Exercise | A | 0.65 | 50,000 | 32,500 | 50,000 | |
Jan 07 2009 | NAVB | NAVIDEA BIOPHARMAC ... | Troup Gordon A | Director | Option Exercise | A | 0.59 | 10,000 | 5,900 | 10,000 | |
Jan 07 2009 | NAVB | NAVIDEA BIOPHARMAC ... | LARSON BRENT L | VP Finance and CFO | Option Exercise | A | 0.59 | 25,000 | 14,750 | 25,000 | |
Jan 07 2009 | NAVB | NAVIDEA BIOPHARMAC ... | Johnson Owen E | Director | Option Exercise | A | 0.59 | 10,000 | 5,900 | 10,000 | |
Jan 07 2009 | NAVB | NAVIDEA BIOPHARMAC ... | BROWN RODGER A | Vice President | Option Exercise | A | 0.59 | 25,000 | 14,750 | 25,000 | |
Jan 07 2009 | NAVB | NAVIDEA BIOPHARMAC ... | Bland Kirby I | Director | Option Exercise | A | 0.59 | 10,000 | 5,900 | 10,000 | |
Jan 07 2009 | NAVB | NAVIDEA BIOPHARMAC ... | AVITAL REUVEN | Director | Option Exercise | A | 0.59 | 10,000 | 5,900 | 10,000 | |
Jan 07 2009 | NAVB | NAVIDEA BIOPHARMAC ... | Rash Douglas L | Vice President, Mar ... | Option Exercise | A | 0.59 | 20,000 | 11,800 | 20,000 | |
Jan 07 2009 | NAVB | NAVIDEA BIOPHARMAC ... | Blair Anthony K | VP-Manufacturing & ... | Option Exercise | A | 0.59 | 25,000 | 14,750 | 25,000 | |
Jan 07 2009 | NAVB | NAVIDEA BIOPHARMAC ... | MILLER FRED B | Director | Option Exercise | A | 0.59 | 10,000 | 5,900 | 10,000 | |
Jan 07 2009 | NAVB | NAVIDEA BIOPHARMAC ... | Aschinger Carl J Jr | Director | Option Exercise | A | 0.59 | 10,000 | 5,900 | 10,000 | |
Sep 16 2008 | NAVB | NAVIDEA BIOPHARMAC ... | Troup Gordon A | Director | Buy | P | 0.68 | 15,000 | 10,200 | 15,000 | 0 to 15 K |
Aug 22 2008 | NAVB | NAVIDEA BIOPHARMAC ... | Johnson Owen E | Director | Buy | P | 0.66 | 20,000 | 13,200 | 20,000 | 0 to 20 K |
Sep 02 2008 | NAVB | NAVIDEA BIOPHARMAC ... | Bland Kirby I | Director | Buy | P | 0.75 | 25,000 | 18,625 | 25,000 | 0 to 25 K |
Aug 21 2008 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Buy | P | 0.62 | 3,095 | 1,919 | 773,500 | 770.4 K to 773.5 K (+0.40 %) |
Aug 21 2008 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Buy | P | 0.64 | 8,200 | 5,248 | 770,405 | 762.2 K to 770.4 K (+1.08 %) |
Aug 21 2008 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Buy | P | 0.65 | 8,705 | 5,658 | 762,205 | 753.5 K to 762.2 K (+1.16 %) |
Aug 18 2008 | NAVB | NAVIDEA BIOPHARMAC ... | WHITLEY J FRANK | Director | Buy | P | 0.65 | 20,000 | 13,000 | 21,500 | 1.5 K to 21.5 K (+1,333.33 %) |
Aug 12 2008 | NAVB | NAVIDEA BIOPHARMAC ... | Aschinger Carl J Jr | Director | Buy | P | 0.68 | 145 | 98 | 1,145 | 1,000 to 1.1 K (+14.50 %) |
Aug 12 2008 | NAVB | NAVIDEA BIOPHARMAC ... | Aschinger Carl J Jr | Director | Buy | P | 0.68 | 14,800 | 9,990 | 151,000 | 136.2 K to 151 K (+10.87 %) |
Aug 13 2008 | NAVB | NAVIDEA BIOPHARMAC ... | AVITAL REUVEN | Director | Buy | P | 0.07 | 29,840 | 1,940 | 80,000 | 50.2 K to 80 K (+59.49 %) |
Aug 12 2008 | NAVB | NAVIDEA BIOPHARMAC ... | AVITAL REUVEN | Director | Buy | P | 0.65 | 25,160 | 16,354 | 50,160 | 25 K to 50.2 K (+100.64 %) |
Aug 12 2008 | NAVB | NAVIDEA BIOPHARMAC ... | AVITAL REUVEN | Director | Buy | P | 0.65 | 5,000 | 3,250 | 25,000 | 20 K to 25 K (+25.00 %) |
Aug 11 2008 | NAVB | NAVIDEA BIOPHARMAC ... | AVITAL REUVEN | Director | Buy | P | 0.65 | 20,000 | 13,000 | 20,000 | 0 to 20 K |
Jul 31 2008 | NAVB | NAVIDEA BIOPHARMAC ... | Troup Gordon A | Director | Option Exercise | A | 0.63 | 10,000 | 6,300 | 10,000 | |
Jun 03 2008 | NAVB | NAVIDEA BIOPHARMAC ... | MILLER FRED B | Director | Buy | P | 0.75 | 10,000 | 7,500 | 81,000 | 71 K to 81 K (+14.08 %) |
Jun 03 2008 | NAVB | NAVIDEA BIOPHARMAC ... | MILLER FRED B | Director | Buy | P | 0.74 | 18,500 | 13,690 | 71,000 | 52.5 K to 71 K (+35.24 %) |
May 30 2008 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Gift | G | 0.00 | 6,765 | 0 | 183,746 | 190.5 K to 183.7 K (-3.55 %) |
May 30 2008 | NAVB | NAVIDEA BIOPHARMAC ... | MILLER FRED B | Director | Buy | P | 0.74 | 6,500 | 4,810 | 71,500 | 65 K to 71.5 K (+10.00 %) |
May 30 2008 | NAVB | NAVIDEA BIOPHARMAC ... | MILLER FRED B | Director | Buy | P | 0.75 | 12,500 | 9,375 | 65,000 | 52.5 K to 65 K (+23.81 %) |
May 30 2008 | NAVB | NAVIDEA BIOPHARMAC ... | MILLER FRED B | Director | Buy | P | 0.70 | 2,500 | 1,750 | 52,500 | 50 K to 52.5 K (+5.00 %) |
Mar 28 2008 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Option Exercise | M | 0.13 | 375,000 | 48,750 | 0 | |
Mar 28 2008 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Gift | G | 0.00 | 15,000 | 0 | 190,511 | 175.5 K to 190.5 K (+8.55 %) |
Mar 28 2008 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Gift | G | 0.00 | 60,000 | 0 | 753,500 | 813.5 K to 753.5 K (-7.38 %) |
Mar 28 2008 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Buy | M | 0.13 | 375,000 | 48,750 | 813,500 | 438.5 K to 813.5 K (+85.52 %) |
Jan 07 2008 | NAVB | NAVIDEA BIOPHARMAC ... | WHITLEY J FRANK | Director | Option Exercise | A | 0.36 | 10,000 | 3,600 | 10,000 |